Preparation method of mouse bone tissue paraffin section for space transcriptome sequencing

By using steps such as fixation with 4% paraformaldehyde and decalcification with EDTA to prepare paraffin sections of bone tissue, the problems of high RNA degradation rate and harsh preservation conditions were solved, and spatial transcriptomics experimental sections with low degradation rate and high reproducibility were achieved. This method is suitable for the preparation of paraffin sections of mouse bone tissue.

CN118979099APending Publication Date: 2024-11-19THE FIRST AFFILIATED HOSPITAL OF ARMY MEDICAL UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411048768.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-01
Publication Date
2024-11-19

AI Technical Summary

Technical Problem

Existing technologies for preparing paraffin sections of bone tissue suffer from problems such as high RNA degradation rates, stringent preservation conditions, and poor reproducibility of experimental results, making it difficult to meet the needs of spatial transcriptomics experiments.

Method used

Bone tissue paraffin sections with low RNA degradation rate were prepared by using steps such as fixation with 4% paraformaldehyde, decalcification with EDTA decalcification solution, dehydration with ethanol, and paraffin embedding, which are suitable for space transcriptome sequencing.

Benefits of technology

This method enables the production of paraffin-embedded bone tissue sections with low RNA degradation rates and 180 days of room temperature preservation, ensuring the reproducibility and reliability of results from space omics experiments and overcoming the shortcomings of traditional methods, such as easy damage to sections and short preservation periods.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118979099A_ABST
    Figure CN118979099A_ABST
Patent Text Reader

Abstract

The invention relates to a preparation method of a mouse bone tissue paraffin section for space transcriptome sequencing, and belongs to the field of pathological research. The method can effectively solve the problem of high RNA degradation rate caused by long treatment time of fixation, decalcification and the like of the special part of the bone. The prepared paraffin section meets the space transcriptome sequencing sample requirements (DV200gt; and the method can be used for analyzing cell composition and gene expression characteristics in focus microenvironments such as bone lesion, tumor metastasis and the like. The invention provides an efficient and reliable method for carrying out space transcriptome sequencing analysis by adopting a precious bone tissue sample, and the method has a wide application value.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of pathological research and relates to a method for preparing mouse bone tissue paraffin sections for spatial transcriptome sequencing. Background Art

[0002] Spatial transcriptomics technology combines high-throughput data with spatially heterogeneous RNA captured by probes to help researchers quickly explore the molecular characteristics of the cellular microenvironment. Sample preparation is the starting point of transcriptomics experiments, and DV200 (the proportion of components greater than 200nt in total RNA) >30% is considered an important indicator for evaluating sample availability. However, because bone tissue contains a large amount of inorganic calcium salts, decalcification is required before sectioning and staining. If the decalcification time is too short, it is difficult to obtain uniformly thick sections. If the decalcification time is too long, the quality of the sections will decrease. Among them, RNA is degraded in large quantities, antigen activity is reduced, and the results of spatial omics experiments are poorly reproducible and less reliable.

[0003] In the past, bone tissue samples for spatial omics were frozen sections. However, such sections were stored under high storage conditions and often suffered from dehydration and oxidation, which caused the tissue to deform. They can only be used under short-term low-temperature storage. Although traditional paraffin sections have advantages such as easy storage, the lack of routine processing with fixed temperature, duration, and solution concentration in the past has resulted in substandard sample quality. Therefore, there is an urgent need to establish a method for preparing paraffin sections of bone tissue for spatial transcriptome experiments in order to study precious bone tissue pathological specimens and analyze the cell composition and gene expression characteristics in the bone lesion microenvironment of bone lesions, tumor bone metastases, etc. Summary of the invention

[0004] In view of this, an object of the present invention is to provide a method for preparing paraffin sections of mouse bone tissue for spatial transcriptome sequencing.

[0005] In order to achieve the above object, the present invention provides the following technical solutions:

[0006] The present invention provides a method for preparing paraffin sections of mouse bone tissue for spatial transcriptome sequencing, comprising the following steps:

[0007] (1) Pretreatment of ex vivo bone tissue;

[0008] (2) Bone tissue fixation: fix with 4% paraformaldehyde at 25°C for 16 h;

[0009] (3) Bone tissue decalcification: decalcification with EDTA decalcification solution at 37°C for 20 h;

[0010] (4) Dehydration and transparency treatment;

[0011] (5) Paraffin embedding and sectioning of bone tissue;

[0012] (6) Quality control of paraffin section samples.

[0013] Furthermore, the ex vivo bone tissue pretreatment in step (1) is: taking the mouse ex vivo bone tissue and soaking it in a 95% ethanol solution for 30 minutes, removing the attached soft tissue and then rinsing it with a 0.9% sodium chloride aqueous solution to remove the residual ethanol. In a specific embodiment of the present invention, the ex vivo bone tissue collection method is: killing 6-8 week old mice (mice weighing about 20g), cutting the hind leg bones from the spine, and obtaining the mouse ex vivo bone tissue.

[0014] Furthermore, the fixation of the bone tissue in step (2) is specifically as follows: the mouse bone tissue is immersed in a 4% paraformaldehyde solution with a pH of 7.4, fixed at room temperature 25°C for 16 hours, and then the bone tissue is removed and rinsed with a 0.9% sodium chloride aqueous solution to remove residual paraformaldehyde.

[0015] Furthermore, the decalcification of the bone tissue in step (3) is specifically as follows: immersing the bone tissue in an EDTA decalcification solution that is 10 times larger than its volume at 37° C. for 20 hours, and then gently rinsing the bone tissue with running water to remove residual decalcification solution.

[0016] Furthermore, the dehydration in step (4) is as follows: placing the bone tissue in a 75% to 85% ethanol solution and a 95% to 100% ethanol solution in turn until it is completely dehydrated; and the transparent treatment is as follows: placing the bone tissue in a xylene I solution and a toluene II solution in turn for 5 minutes each.

[0017] Furthermore, the paraffin embedding of the bone tissue in step (5) is as follows: placing the bone tissue block in a pre-soak solution (a mixed solution of n-butanol and paraffin in a volume ratio of 1:2) for 4 to 5 hours and then placing it in a melted mixed wax solution (a mixture of paraffin and beeswax in a ratio of 80 to 90%:10 to 20%) for 4 to 6 hours until solidified.

[0018] Furthermore, the sectioning in step (5) is as follows: the solidified wax block is cut into wax slices with a thickness of 3 μm, which are unfolded in a water bath at 38 to 45° C., and then the wax slices are dried at 37° C. and then immersed in xylene I and xylene II for 8 to 15 minutes respectively, and then the wax slices are placed in anhydrous ethanol, 85 to 95% ethanol, and 65 to 75% ethanol for 1 to 3 minutes respectively for rehydration treatment; the wax slices are placed in distilled water for 2 to 5 minutes, and then the wax slices are stained with eosin for 8 to 10 minutes, and then the wax slices are dehydrated step by step with 65 to 75% ethanol, 80 to 85% ethanol, 90 to 95% ethanol I, 90 to 95% ethanol II, and anhydrous ethanol for 1 to 3 minutes respectively, and then the wax slices are placed in xylene I and xylene II for 5 minutes respectively for transparency treatment, and the sections are sealed with neutral gum.

[0019] Furthermore, the sample quality control of the paraffin section of bone tissue in step (6) is as follows: determining the chip placement position according to the H&E staining results, and performing whole transcriptome probe-mediated RNA detection on the section after de-crosslinking the sample.

[0020] The beneficial effects of the present invention are:

[0021] The present invention obtains bone tissue paraffin section samples that can meet sample RNA quality control (DV200>30%) and are used for spatial transcriptomics experiments by pretreating bone tissue before preparation (including fixation at 25°C for 16 hours and decalcification at 37°C for 20 hours), and then performing conventional paraffin embedding and slicing on the bone tissue.

[0022] The method of the present invention is a preparation method different from the traditional bone tissue paraffin sections with high RNA degradation rate (existing patent technologies: CN112816295A, CN 110618010 A). The present invention is the first to establish a method for preparing bone tissue paraffin sections with low RNA degradation rate, room temperature storage for 180 days, not easy to damage, and spatial omics experimental results with good repeatability and high credibility, overcoming the technical difficulties of traditional bone tissue frozen section samples that are easily damaged, can only be stored at 4°C and used within 7 days.

[0023] Other advantages, objectives and features of the present invention will be described in the following description to some extent, and to some extent, will be obvious to those skilled in the art based on the following examination and study, or can be taught from the practice of the present invention. The objectives and other advantages of the present invention can be realized and obtained through the following description. BRIEF DESCRIPTION OF THE DRAWINGS

[0024] In order to make the purpose, technical solutions and advantages of the present invention more clear, the present invention will be described in detail below in conjunction with the accompanying drawings, wherein:

[0025] Figure 1 The soft tissues on the bone to be fixed have been completely removed except for ligaments and cartilage.

[0026] Figure 2 This is a bone scan image from a Micro CT instrument. Figure 2 A: fixation treatment for 16 h, decalcification treatment for 16 h; Figure 2 B: fixation treatment for 16 h and decalcification treatment for 18 h; Figure 2 C: fixation treatment for 16 h and decalcification treatment for 20 h; Figure 2 D: fixation treatment for 16 h and decalcification treatment for 22 h; Figure 2E was fixed with Bouin's solution (75 ml of 1.22% picric acid saturated solution, 25 ml of formalin, and 5 ml of glacial acetic acid) for 16 h, and then treated with decalcification solution (2.34% hydrochloric acid solution, 99% formaldehyde solution, and distilled water in a volume ratio of 2:10:88) with a pH value of 1.35 for 30 min; Figure 2 There are no highlights in C and 2D, indicating complete decalcification.

[0027] Figure 3 This is the spatial transcriptome chip preparation image of bone tissue samples after fixation for 16 hours and decalcification at 37℃ for 20 hours. Figure 3 A is a diagram of the placement of a 11×11 mm chip on a paraffin section of HE-stained bone tissue (the red dotted box in the figure indicates the chip). Figure 3 B is the HE staining image of the paraffin section of bone tissue covered by the chip. Figure 3 C is the spatial transcriptome organization map of bone tissue paraffin sections covered by the chip.

[0028] Figure 4 DV200 values ​​after fixation for 16 h and decalcification for 16, 18, 20, and 22 h at 37°C.

[0029] Figure 5 Figures 5A and 5A are the gel electrophoresis analysis of RNA in bone tissue sections under different treatments. Figure 5A is the RNA detection of bone tissue samples fixed for 16 h and decalcified at 37 °C for 16 h. Figure 5 B is the RNA detection diagram of bone tissue samples fixed for 16 hours and decalcified at 37°C for 18 hours; Figure 5 C is the RNA detection diagram of bone tissue samples fixed for 16 h and decalcified at 37°C for 20 h; Figure 5 D was fixed for 16 h and decalcified at 37 °C for 22 h; Figure 5 E is a graph showing RNA detection of a bone tissue sample fixed with Bouin's solution for 16 hours and then treated with a decalcifying solution (composed of 2.34% hydrochloric acid solution, 99% formaldehyde solution and distilled water in a volume ratio of 2:10:88) with a pH value of 1.35 for 30 minutes.

[0030] Figure 6 Figure 6 is the result of the Agilent 2100 bioanalyzer test, and 6A is the RNA detection graph of the bone tissue sample fixed for 16 hours and decalcified at 37°C for 16 hours; Figure 6 B is the RNA detection diagram of bone tissue samples fixed for 16 hours and decalcified at 37°C for 18 hours; Figure 6 C is the RNA detection diagram of bone tissue samples fixed for 16 h and decalcified at 37°C for 20 h; Figure 6 D was fixed for 16 h and decalcified at 37 °C for 22 h; Figure 6E is a graph showing RNA detection of a bone tissue sample fixed with Bouin's solution for 16 hours and then treated with a decalcifying solution (composed of 2.34% hydrochloric acid solution, 99% formaldehyde solution and distilled water in a volume ratio of 2:10:88) with a pH value of 1.35 for 30 minutes.

[0031] Figure 7 Bone tissue samples were fixed for 16 h and decalcified at 37°C for 20 h, and the DV200 values ​​of bone sections were measured on days 0, 30, 60, 90, 120, 150, and 180.

[0032] Figure 8 The results of the Agilent 2100 bioanalyzer test were shown for the bone tissue sample after fixation for 16 hours and decalcification at 37°C for 20 hours. Figure 8 A, B, C, D, E, F, and G are the electropherograms detected by Agilent 2100 bioanalyzer on day 0, day 30, day 60, day 90, day 120, day 150, and day 180, respectively.

[0033] Fig. 9 The results of the Agilent 2100 bioanalyzer test were shown for the bone tissue sample after fixation for 16 hours and decalcification at 37°C for 20 hours. Fig. 9 A, B, C, D, E, F, and G are the RIN values ​​detected by Agilent 2100 bioanalyzer on day 0, day 30, day 60, day 90, day 120, day 150, and day 180, respectively.

[0034] Fig.10 tSNE diagram of spatial transcriptome analysis of bone tissue samples after fixation for 16 hours and decalcification at 37℃ for 20 hours. The cells are divided into 32 different clusters (C0-31), among which C0, 18, 20, 22, and 26 are endothelial cells, C1, 7, 8, 9, 14, 15, 17, 23, and 28 are lymphocytes, C3, 5, and 12 are osteoblasts, C4 is a fibroblast, C2, 6, 10, 13, 16, and 21 are mesenchymal stem cells, C11 is a hematopoietic stem cell, C19, 25, and 29 are osteoclasts, and C24, 27, 30, and 31 are mononuclear macrophages. DETAILED DESCRIPTION

[0035] The following describes the embodiments of the present invention through specific examples, and those skilled in the art can easily understand other advantages and effects of the present invention from the contents disclosed in this specification. The present invention can also be implemented or applied through other different specific embodiments, and the details in this specification can also be modified or changed in various ways based on different viewpoints and applications without departing from the spirit of the present invention.

[0036] Example 1

[0037] 1. Pretreatment of ex vivo bone tissue

[0038] (1) 6-8 week old C57BL / 6NCrl SPF grade (Beijing Weitonglihua Experimental Animal Technology Co., Ltd., Cat. No. C57BL / 6NCrl mouse SPF grade) mice (weighing about 20 g) were killed, the spine was transversely cut at L3, and the hind leg bones on both sides were cut;

[0039] (2) Take the hind leg bones containing skin and soft tissue and soak them in 95% ethanol (Sangon, Cat. No. A500737-0005) solution for 30 min;

[0040] (3) Remove the attached soft tissue and rinse three times with 0.9% sodium chloride aqueous solution (Beyotime, Cat. No. ST341) to remove the residual ethanol. Figure 1 As shown, the soft tissue of the bone sample has been completely removed, but the ligaments and cartilage have been preserved.

[0041] 2. Bone tissue fixation

[0042] (1) The bone tissue obtained in step 1 was fixed in a 4% paraformaldehyde solution (Beyotime, Cat. No. P0099) with a pH of 7.4 at 25° C. for 16 h;

[0043] (2) Rinse three times with 0.9% sodium chloride aqueous solution to fully remove residual paraformaldehyde.

[0044] 3. Decalcification of bone tissue

[0045] (1) The bone tissue was immersed in EDTA decalcification solution (Biosharp, Cat. No. BL616B) with a volume 10 times greater than its volume at 37°C for 16 h, 18 h, 20 h, or 22 h;

[0046] (2) Gently rinse the bone tissue with running water at room temperature for 2 hours.

[0047] 4. Micro CT evaluation of bone decalcification

[0048] Micro CT equipment was used to perform bone scanning to observe the decalcification of bones after different decalcification times. If there was no bright signal, it meant that decalcification was complete. Figure 2 As shown, Figure 2 There are no highlights in C and 2D, which indicates that decalcification has been complete after more than 20 hours of decalcification.

[0049] 5. Paraffin Embedding of Bone Tissue

[0050] (1) Dehydration treatment: The decalcified bone tissue was placed in a 75% ethanol solution for 12.5 h and a 95% ethanol solution for 8 h.

[0051] (2) Transparent treatment: Place the bone tissue in xylene I and xylene II solution for 5 min each;

[0052] (3) The bone tissue block was placed in a pre-soak solution (a mixed solution of n-butanol and paraffin in a volume ratio of 1:2) for 4.5 h and then placed in a melted mixed wax solution (a mixture of paraffin and beeswax in a ratio of 85%:15%) for 5 h until solidified;

[0053] 6. Preparation of paraffin sections of bone tissue

[0054] (1) Cut the solidified wax block into 3 μm thick wax slices, and then place them in a 40°C water bath for development;

[0055] (2) Dry the wax sheet at 37°C;

[0056] (3) Soak the wax sheet in xylene I and xylene II for 10 min each;

[0057] (4) Place the wax sheet in anhydrous ethanol, 85% ethanol, and 75% ethanol for 2.5 min each for rehydration;

[0058] (5) Soak the wax sheet in distilled water for 3 min;

[0059] (6) Stain the wax slide with eosin for 10 min;

[0060] (7) Dehydrate the wax slides in 75% ethanol, 85% ethanol, 95% ethanol I, 95% ethanol II, and anhydrous ethanol for 3 min each;

[0061] (8) Place the wax sheet in xylene I and xylene II for 5 min each for transparent treatment;

[0062] (9) Use neutral gum to seal the sections.

[0063] 7. Sample quality control of paraffin sections of bone tissue

[0064] (1) Perform H&E staining on paraffin sections of bone tissue. According to the results of H&E staining, place the 11 mm*11 mm chip at the site to be tested, and record the tissue morphology and spot position using a bright field microscope. The chip is placed as follows: Figure 3 As shown in A, HE staining of the paraffin section of bone tissue covered by the chip is as follows Figure 3 As shown in B.

[0065] (2) The samples were decrosslinked, and the raw data was captured using poly(dT) technology and input into the space ranger to compare the spot positions, obtaining the spots covered under the chip as valid spots. Figure 3 C. The barcode information corresponding to the valid spot is obtained by combining the chip serial number. Based on the valid barcode information, the quality, saturation and validity of the sequencing data are evaluated. The results are shown in Figure 4 , 5 , 6. The results showed that the DV200 of paraffin sections of bone tissue fixed for 16 hours and decalcified for 20 hours at 37°C was >30% and the RNA degradation rate was the lowest.

[0066] (3) Paraffin sections were stored at room temperature and analyzed using an Agilent 2100 bioanalyzer on days 0, 30, 60, 90, 120, 150, and 180. The results were as follows: Figure 7 , Figure 8 and Fig. 9 The results showed that the DV200 value, electrophoresis results and RIN value of paraffin sections of bone tissue stored at room temperature for 180 days were stable.

[0067] (4) Use tissue optimization chips to optimize tissue permeabilization time. Time gradient permeabilization, fluorescence reverse transcription, tissue removal and fluorescence imaging were performed in sequence, and finally the spatial transcriptome library was prepared using a library preparation chip. According to the endothelial cell clustering markers: PECAM1, KDR, CD34, Eng, Mcam, vwf; osteoblast clustering markers: DMP1, PHEX, FGF23, RUNX2, ALPL, BGLAP; fibroblast clustering markers: DCN, COL1A1; mesenchymal stem cell clustering markers: ITGB1, CD44; hematopoietic stem cell clustering markers: CD34, PTPRC; osteoclast clustering markers: ACP5, CTSK, MMP9, NFATC1; monocyte macrophage, clustering markers: CSF1R, TNFRSF11A, the cells were divided into 32 different clusters (C0-31) and 7 groups (endothelial cells, osteoblasts, fibroblasts, mesenchymal stem cells, hematopoietic stem cells, osteoclasts, monocyte macrophages). The results are shown in Figure 2 Fig.10 As shown, the results indicate that the spatial transcriptome sequencing of the slices prepared by the method of the present invention was successful.

[0068] Example 2 Comparative Example

[0069] 1. Pretreatment of ex vivo bone tissue

[0070] Same as Example 1.

[0071] 2. Fixation-Decalcification:

[0072] The bone tissue obtained in step 1 was fixed with Bouin's solution for 16 hours and then treated with decalcification solution for 30 minutes. Micro CT was used to evaluate the decalcification of the bone tissue. The results were as follows: Figure 2 As shown in Figure E, it can be seen from the figure that the sample is not completely decalcified. The decalcification solution is composed of hydrochloric acid (mass fraction is 2.34%), formaldehyde and distilled water in a volume ratio of 2:10:88, and its pH value is 1.35.

[0073] 3. Gradient dehydration:

[0074] Soak in 10% formalin for 1 hour, soak in 75% alcohol for 1 hour, soak in 95% alcohol for 1 hour, repeat once, soak in 95% alcohol for 1 hour, soak in anhydrous alcohol for 1 hour, repeat twice, soak in anhydrous alcohol for 1 hour, soak in xylene for 40 minutes, repeat twice, soak in xylene for 40 minutes, soak in paraffin for 1 hour, repeat paraffin soaking twice.

[0075] 4. Paraffin Embedding:

[0076] Same as Example 1.

[0077] 5. Paraffin sections:

[0078] The wax block was cut into 3 μm slices, unfolded in a water bath at 38-45°C, and the wax slices were dried; the dried wax slices were dewaxed with xylene I and xylene II for 10 min each, and the dewaxed wax slices were rehydrated with anhydrous ethanol, 95% ethanol, 80% ethanol, and 70% ethanol in a gradient manner, each for 3 min, and the wax slices after step-by-step rehydration were placed in distilled water for 5 min, taken out from the distilled water and stained with eosin for 10 min; the stained wax slices were dehydrated and transparentized step by step, and then sealed with neutral gum.

[0079] 6. Sample quality control of paraffin sections of bone tissue

[0080] The samples were decrosslinked, and the raw data were captured using poly(dT) technology and input into the space ranger. The spot positions were compared and the spots covered under the tissue sections were obtained as valid spots. DV200 was measured. The results were as follows: Figure 5 As shown in E and 6E, the DV200 of the obtained paraffin sections of bone tissue was <30%, and the RNA degradation rate was high, which could not be used for spatial transcriptome sequencing.

[0081] Finally, it should be noted that the above embodiments are only used to illustrate the technical solution of the present invention rather than to limit it. Although the present invention has been described in detail with reference to the preferred embodiments, those skilled in the art should understand that the technical solution of the present invention can be modified or replaced by equivalents without departing from the purpose and scope of the technical solution, which should be included in the scope of the claims of the present invention.

Claims

1. A method for preparing paraffin sections of mouse bone tissue for spatial transcriptome sequencing, It is characterized in that include: (1) Pretreatment of ex vivo bone tissue; (2) Bone tissue fixation: fix with 4% paraformaldehyde at 25°C for 16 h; (3) Bone tissue decalcification: decalcification with EDTA decalcification solution at 37°C for 20 h; (4) Dehydration and transparency treatment; (5) Paraffin embedding and sectioning of bone tissue; (6) Quality control of paraffin section samples.

2. The method according to claim 1, It is characterized in that Step (1) specifically comprises: taking mouse ex vivo bone tissue and immersing it in 95% ethanol solution or anhydrous ethanol, removing attached soft tissue and then rinsing with 0.9% sodium chloride aqueous solution to remove residual ethanol.

3. The method according to claim 1, It is characterized in that In step (2), after the bone tissue is fixed, the bone tissue is removed and rinsed with a 0.9% sodium chloride aqueous solution to remove residual paraformaldehyde.

4. The method according to claim 1, It is characterized in that After the bone tissue is treated with the decalcification solution in step (3), the bone tissue is gently rinsed with running water to remove the residual decalcification solution.

5. The method according to claim 1, It is characterized in that Step (4) is specifically as follows: placing the bone tissue in a 75% to 85% ethanol solution and a 95% to 100% ethanol solution in turn until it is completely dehydrated, and then placing the bone tissue in a xylene I solution and a toluene II solution in turn for 5 minutes each.

6. The method according to claim 1, It is characterized in that Step (5) specifically includes placing the bone tissue block in the pre-soak solution for 4 to 5 hours and then placing it in the melted mixed wax solution for 4 to 6 hours until solidified, and then slicing the wax block for later use.

7. The method according to claim 1, It is characterized in that The quality control method in step (6) is: performing whole transcriptome probe-mediated RNA detection on paraffin sections.

8. The method according to claim 6, It is characterized in that The pre-soaking liquid is a mixed solution of n-butanol and paraffin in a volume ratio of 1:

2.

9. The method according to claim 6, It is characterized in that The mixed wax liquid is a mixture of paraffin wax and beeswax in a ratio of 80-90%:10-20%.

10. The method according to claim 6, It is characterized in that The slice thickness is 3 μm.